Enzyme Research Frontiers

Explore cutting-edge studies on enzyme kinetics, structure, and industrial applications

Research Articles

Irinogenetics: How Your DNA Guides Cancer Chemotherapy

Discover how genetics influence irinotecan chemotherapy response through UGT1A1 polymorphisms and personalized cancer treatment approaches.

Lillian Cooper
Nov 02, 2025

A New Ally in the Fight: Exploring Pemetrexed's Role in Breast Cancer Treatment

Clinical experience with pemetrexed in breast cancer treatment, exploring its mechanism, clinical trials, and therapeutic applications.

Samantha Morgan
Oct 27, 2025

Iron Two Against Cancer: The Promise of Diiron Vinyliminium Complexes

Exploring the potential of diiron vinyliminium complexes as next-generation anticancer agents with novel mechanisms of action.

Noah Brooks
Oct 24, 2025

The Genetic Key to Predicting Chemotherapy Side Effects: How Your DNA Influences Treatment Toxicity

Explore how GSTP1 genetic polymorphism affects toxicity in platinum-based chemotherapy and the future of personalized cancer treatment.

Elizabeth Butler
Oct 21, 2025

Disarming the Bodyguard: How a New Strategy Could Make Chemotherapy Work Better

Discover how inhibiting the PI3K/Akt pathway can resensitize gastric cancer to chemotherapy drugs like vincristine, offering new hope for cancer treatment.

Ellie Ward
Oct 20, 2025

Targeting the Tumor's Lifeline: A New Hope for Liver Cancer Treatment

How a refined hepatic artery infusion (HAI) model is revolutionizing liver cancer treatment through direct drug delivery

Levi James
Oct 13, 2025

The Great Escape: How Cancer Cells Evade Our Most Powerful Drugs

Discover how cancer cells use ABCB1 pumps to expel both chemotherapy drugs and their metabolites, creating powerful treatment resistance.

Levi James
Oct 10, 2025

The Sugar Shield: How a Hidden RNA Makes Lung Cancer Resistant to Chemo

Discover how lncRNA XIST helps lung cancer cells resist chemotherapy by turning them into sugar-guzzling factories through cellular glycolysis.

Joseph James
Oct 02, 2025

The Triple Threat: How a Three-Drug Combo is Rewriting the Rules of Cancer Therapy

Exploring the groundbreaking three-drug combination of pemetrexed, gemcitabine, and cisplatin in cancer therapy through phase I clinical trials.

Grace Richardson
Aug 12, 2025

Popular Articles